Hong Pei Selected Research

Catenins

11/2021

CCAR2 promotes a malignant phenotype of osteosarcoma through Wnt/β-catenin-dependent transcriptional activation of SPARC.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Pei Research Topics

Disease

8	Atherosclerosis 01/2018 - 03/2004
6	Neoplasms (Cancer) 11/2021 - 02/2015
6	Inflammation (Inflammations) 01/2021 - 01/2006
3	Obesity 02/2012 - 11/2008
2	Osteosarcoma (Osteogenic Sarcoma) 11/2021 - 12/2018
2	Reperfusion Injury 02/2012 - 05/2010
2	Insulin Resistance 01/2011 - 11/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011 - 01/2006
2	Hyperlipidemias (Hyperlipidemia) 07/2006 - 04/2005
1	Essential Hypertension 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Knee Osteoarthritis 09/2019
1	Hepatocellular Carcinoma (Hepatoma) 12/2018
1	Asthma (Bronchial Asthma) 01/2016
1	Infections 01/2016
1	Respiratory Hypersensitivity 01/2016
1	Hypertension (High Blood Pressure) 12/2015
1	Chronic Disease (Chronic Diseases) 12/2015
1	Body Weight (Weight, Body) 12/2015
1	Anemia 09/2015
1	Neoplasm Metastasis (Metastasis) 05/2015
1	Prostatic Neoplasms (Prostate Cancer) 05/2015
1	Low Back Pain (Lumbago) 10/2014
1	Hyperglycemia 02/2012
1	Hyperinsulinism (Hyperinsulinemia) 02/2012
1	Aneurysm (Aneurysms) 12/2009
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2009
1	Hyperplasia 11/2008
1	Neointima 01/2006

Drug/Important Bio-Agent (IBA)

4	ApolipoproteinsIBA 01/2018 - 11/2004
3	EnzymesIBA 01/2021 - 11/2008
3	Apolipoproteins E (ApoE)IBA 02/2012 - 04/2005
2	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021 - 12/2015
2	AllergensIBA 01/2021 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 01/2011
2	CytokinesIBA 12/2015 - 01/2011
2	Messenger RNA (mRNA)IBA 05/2015 - 02/2012
2	MicroRNAs (MicroRNA)IBA 05/2015 - 02/2015
2	Proteins (Proteins, Gene)FDA Link 05/2015 - 02/2012
2	Insulin (Novolin)FDA Link 02/2012 - 01/2006
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 11/2008 - 03/2004
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2006 - 04/2005
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	CateninsIBA 11/2021
1	Biological ProductsIBA 11/2021
1	Adenosine DeaminaseIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2020
1	TNF Receptor-Associated Factor 3IBA 09/2019
1	Peptide Hydrolases (Proteases)FDA Link 12/2018
1	UbiquitinIBA 12/2018
1	MF59 oil emulsionIBA 01/2018
1	SqualeneIBA 01/2018
1	Apolipoproteins B (ApoB)IBA 01/2018
1	incomplete Freund's adjuvantIBA 01/2018
1	VaccinesIBA 01/2018
1	Peptides (Polypeptides)IBA 01/2018
1	Methacholine Chloride (Methacholine)FDA Link 01/2016
1	Interleukin-12 (IL 12)IBA 01/2016
1	LipopolysaccharidesIBA 12/2015
1	GlobinsIBA 09/2015
1	thiazolyl blueIBA 05/2015
1	Zinc Finger E-box-Binding Homeobox 1IBA 05/2015
1	Cisplatin (Platino)FDA LinkGeneric 05/2015
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 05/2015
1	Immunoglobulin M (IgM)IBA 02/2012
1	Interleukin-17 (Interleukin 17)IBA 02/2012
1	AutoantibodiesIBA 02/2012
1	Toll-Like Receptor 4IBA 02/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2012
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 02/2012
1	Member 1 Group A Nuclear Receptor Subfamily 4IBA 02/2012
1	ArginaseIBA 02/2012
1	Insulin Receptor Substrate ProteinsIBA 02/2012
1	Insulin ReceptorIBA 02/2012
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2011
1	Reducing AgentsIBA 01/2011
1	Matrix Metalloproteinases (MMPs)IBA 12/2009
1	Actins (F Actin)IBA 12/2009
1	Pancreatic Elastase (Elastase)IBA 12/2009
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 12/2009
1	Caspase 3 (Caspase-3)IBA 11/2008
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2008
1	LDL Receptors (LDL Receptor)IBA 07/2006
1	Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA 01/2006
1	P-SelectinIBA 04/2005

Therapy/Procedure

3	Therapeutics 01/2021 - 12/2009
1	Immunotherapy 01/2021
1	Massage (Zone Therapy) 10/2014
1	Heart Transplantation (Grafting, Heart) 05/2010